Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
NCT: NCT06893341 · RECRUITING
NCT IDNCT06893341
StatusRECRUITING
Start Date2025-10-23
Completion2026-12-01
Brief Summary
The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.
Frequently Asked Questions
What is Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events?
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events is a clinical trial registered under NCT06893341. Current status: RECRUITING.
What is the status of NCT06893341?
The current status of NCT06893341 (Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events) is: RECRUITING.
When did Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events start?
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events started on 2025-10-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.